Skip to content

Pulse Oximetry Errors in Hospitalized Patients Across Varying Skin Pigmentation

Prospective Clinical Study of Pulse Oximeter Errors in Hospitalized Patients With Varying Skin Pigmentation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05554510
Acronym
EquiOx
Enrollment
757
Registered
2022-09-26
Start date
2022-08-14
Completion date
2024-08-20
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxemia, Pulse Oximetry, Skin Pigment

Keywords

Hospitalized Patients

Brief summary

This is a prospective observational study designed to quantify and understand errors in pulse oximetry in hospitalized patients in relation to their skin pigmentation. It is driven by three recent retrospective studies showing missed diagnosis of hypoxemia in patients across a spectrum of skin pigmentation, defined as blood SaO2 \<90% when their pulse oximeter reads 92% or greater.

Detailed description

This prospective study will overcome the limitations of earlier retrospective studies using three important study protocols: 1. precise time-matching paired blood gas samples to stable periods of pulse oximeter readings 2. objective quantification of skin pigmentation rather than using documented or self-reported race 3. collection of high quality pulse oximeter tracing data, and identifying potential mediators of discordance of noninvasive and invasive measurements such as low perfusion states. The primary aim is to quantify the bias in SpO2 measurements across skin pigmentation groups in a real-world setting against the gold standard of invasive measurements of arterial blood oxygen saturation measurements across categories of skin pigmentation. These data are essential to addressing health equity and patient safety for people of all skin pigmentations.

Interventions

OTHERObservational

No interventions planned. Observational data collection only.

Sponsors

Food and Drug Administration (FDA)
CollaboratorFED
University of California, San Francisco
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * hospitalized and at high risk of hypoxemia, defined as saturations \< 90%, * patients with arterial line in place for clinical purposes

Exclusion criteria

* Profound anemia, defined as hemoglobin \< 8 g/dl will preclude blood draws for research purposes * Known pregnancy * In custody of law enforcement officials

Design outcomes

Primary

MeasureTime frameDescription
Pulse Oximetry ErrorsUp to 10 simultaneous, paired arterial blood samples and noninvasive pulse oximeter readings obtained during unpredictable qualifying episodes of low oxygen saturation identified by clinically indicated monitoring over a 14-day study periodPulse oximeter bias (difference between SpO2 and SaO2)

Secondary

MeasureTime frameDescription
Occult Hypoxemia RatesUp to 10 simultaneous, paired arterial blood samples and noninvasive pulse oximeter readings obtained during unpredictable qualifying episodes of low oxygen saturation identified by clinically indicated monitoring over a 14-day study periodEpisodes of arterial blood gas functional saturation \<90% with simultaneous pulse oximeter reading \>/=92%

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026